These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 31591315)

  • 1. In Silico and In Vitro Anti-
    Fong P; Hao CH; Io CC; Sin PI; Meng LR
    Molecules; 2019 Oct; 24(19):. PubMed ID: 31591315
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro assessment of Helicobacter pylori ureases inhibition by honey fractions.
    Matongo F; Nwodo UU
    Arch Med Res; 2014 Oct; 45(7):540-6. PubMed ID: 25240315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-silico Designing, ADMET Analysis, Synthesis and Biological Evaluation of Novel Derivatives of Diosmin Against Urease Protein and Helicobacter pylori Bacterium.
    Kataria R; Khatkar A
    Curr Top Med Chem; 2019; 19(29):2658-2675. PubMed ID: 31724503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preliminary study on in-vitro induction of antibiotic resistance in Helicobacter pylori strains isolated from children].
    Yan WH; Chen J; Hu HJ; Yu JD; Huang XL; Li ZY
    Zhonghua Er Ke Za Zhi; 2007 Sep; 45(9):708-11. PubMed ID: 18021568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of fosfomycin alone and in combination with amoxicillin, clarithromycin and metronidazole against Helicobacter pylori compared with combined clarithromycin and metronidazole.
    Blacky A; Makristathis A; Apfalter P; Willinger B; Rotter ML; Hirschl AM
    Eur J Clin Microbiol Infect Dis; 2005 Apr; 24(4):276-9. PubMed ID: 15902535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Helicobacter pylori and Its Associate Urease by Labdane Diterpenoids Isolated from Andrographis paniculata.
    Shaikh RU; Dawane AA; Pawar RP; Gond DS; Meshram RJ; Gacche RN
    Phytother Res; 2016 Mar; 30(3):412-7. PubMed ID: 26648323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective antibacterial activity of patchouli alcohol against Helicobacter pylori based on inhibition of urease.
    Yu XD; Xie JH; Wang YH; Li YC; Mo ZZ; Zheng YF; Su JY; Liang YE; Liang JZ; Su ZR; Huang P
    Phytother Res; 2015 Jan; 29(1):67-72. PubMed ID: 25243578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Helicobacter pylori biofilm formation on susceptibility to amoxicillin, metronidazole and clarithromycin.
    Yonezawa H; Osaki T; Hojo F; Kamiya S
    Microb Pathog; 2019 Jul; 132():100-108. PubMed ID: 31034965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug susceptibility pattern of Helicobacter pylori in patients with dyspepsia at the Kenyatta National Hospital, Nairobi.
    Lwai-Lume L; Ogutu EO; Amayo EO; Kariuki S
    East Afr Med J; 2005 Dec; 82(12):603-8. PubMed ID: 16619703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of anti-ulcer agents on antibiotic activity against Helicobacter pylori.
    Sunairi M; Watanabe K; Suzuki T; Tanaka N; Kuwayama H; Nakajima M
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S121-4. PubMed ID: 7735928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of Helicobacter pylori resistance to antibiotics in Northeast Italy: a multicentre study. GISU. Interdisciplinary Group for the Study of Ulcer.
    Pilotto A; Rassu M; Leandro G; Franceschi M; Di Mario F;
    Dig Liver Dis; 2000 Dec; 32(9):763-8. PubMed ID: 11215555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting growth and antibiotic susceptibility of Helicobacter pylori: effect of pH and urea on the survival of a wild-type strain and a urease-deficient mutant.
    Sjöström JE; Larsson H
    J Med Microbiol; 1996 Jun; 44(6):425-33. PubMed ID: 8636959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of plaunotol in combination with clarithromycin or amoxicillin on Helicobacter pylori in vitro and in vivo.
    Koga T; Inoue H; Ishii C; Okazaki Y; Domon H; Utsui Y
    J Antimicrob Chemother; 2002 Jul; 50(1):133-6. PubMed ID: 12096020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Silico Profiling of the Potentiality of Curcumin and Conventional Drugs for CagA Oncoprotein Inactivation.
    Srivastava AK; Tewari M; Shukla HS; Roy BK
    Arch Pharm (Weinheim); 2015 Aug; 348(8):548-55. PubMed ID: 25996140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A combination effect of epigallocatechin gallate, a major compound of green tea catechins, with antibiotics on Helicobacter pylori growth in vitro.
    Yanagawa Y; Yamamoto Y; Hara Y; Shimamura T
    Curr Microbiol; 2003 Sep; 47(3):244-9. PubMed ID: 14570277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does emerging Clarithromycin resistance signal an obituary to empirical standard triple therapy for Helicobacter pylori infection?
    John A; Al Kaabi S; Doiphode S; Chandra P; Sharma M; Babu R; Yacoub R; Derbala M
    Indian J Gastroenterol; 2015 Sep; 34(5):404-7. PubMed ID: 26541342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the preliminary susceptibility testing for initial and after failed therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and esomeprazole.
    Marzio L; Coraggio D; Capodicasa S; Grossi L; Cappello G
    Helicobacter; 2006 Aug; 11(4):237-42. PubMed ID: 16882326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro anti-bactrical activity and its preliminary mechanism of action of the non-medicinal parts of Sanguisorba officinalis L. against Helicobacter pylori infection.
    Chen P; Chen M; Peng C; Yan J; Shen X; Zhang W; Yuan Y; Gan G; Luo X; Zhu W; Yao M
    J Ethnopharmacol; 2024 Jan; 318(Pt B):116981. PubMed ID: 37574016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antimicrobial susceptibility of Helicobacter pylori with chronic gastritis].
    Figueroa M; Cortés A; Pazos Á; Bravo LE
    Biomedica; 2012; 32(1):32-42. PubMed ID: 23235785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helicobacter pylori resistance to six antibiotics by two breakpoint systems and resistance evolution in Bulgaria.
    Boyanova L; Gergova G; Evstatiev I; Spassova Z; Kandilarov N; Yaneva P; Markovska R; Mitov I
    Infect Dis (Lond); 2016; 48(1):56-62. PubMed ID: 26465202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.